SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 27 Sep, 2014  

UBM India to Organise Nutraceuticals 2013 Conference

PR Newswire | 18 Jul, 2013
MUMBAI, India: The nutraceuticals market in India is expected to grow tremendously in the next five years. Indian nutraceuticals market revenues are expected to reach approximately USD 4.2 Billion in 2017. The market is being strongly driven by the increasing health consciousness, rising disposable incomes, increasing number of people being affected by lifestyle diseases resulting in greater healthcare spending. The companies operating in this market are aiming to attain higher product visibility and the market players of the nutraceuticals market are focusing on industry expansion to boost the growth of an already expanding OTC market. In addition, the growth of the nutraceuticals market has also been contributed to by easy availability and accessibility of healthy foods in developing nations, inclination towards healthy lifestyle and introduction of foods targeted at specific diseases and deficiencies. However, the industry is still in a nascent stage and holds ample opportunity to grow in future. There is a strong need for regulatory clarity, developing customized products, affordable pricing and distribution strategy.

Based on the past research and valuable insights shared by 50 senior Industry experts working in the nutraceuticals industry, UBM India has organised a strategic conference, 2nd Annual Nutraceuticals 2013 Forum, under Fi Brand by UBM and will be focused to provide in-depth guidance on the latest evolving domestic and global regulations, nutraceuticals market dynamics in India, on-going trends and consumer behaviour, and sustainable market-centric business strategies to drive nutraceutical product development in the country.

Also, there will be a pre-conference regulatory seminar on 28 August focusing on domestic and global nutraceutical regulations and will be presided by B Sesikeran, Director, National Institute of Nutrition, Hyderabad and Panel Member of Scientific Panel on Labelling and Claims, FSSAI. The 2-day strategic conference on 29-30 August will be led by thought leaders from British Biologicals, Plethico Pharmaceuticals, Zydus Nutriva, Unimark Remedies, nutriConnect, Marico, Abbott Nutrition and many more.

This unique 3-day strategic conference will bring together 120+ Vice Presidents, Directors, Heads of Regulatory, R&D, Production Innovation and Production Development department professionals from food, beverage and pharmaceutical industry all under one roof. For more information, visit http://www.nutraceuticals-india.com/pr

About UBM India:

UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. http://www.ubmindia.in

Contact: Shwetha Prabhu, conferences-india@ubm.com, +91(0)22-61727001

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter